Physician profile
Mark Sisco
NPI 1245498658
$308,885.76
in general payments reported to CMS, 2019-2025
11 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $75.17 · 2021: $23.09 · 2022: $307K · 2023: $133 · 2024: $973 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $812 · Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $812.00 |
| Food and Beverage | $516.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $306,859.00 | 2022 | |
| Abbvie INC. | $1,092.48 | 2024-2025 | |
| Intuitive Surgical, INC. | $413.34 | 2019 | |
| Allergan, INC. | $174.83 | 2019-2022 | |
| Integra Lifesciences Corporation | $115.72 | 2019-2023 | Durasorb Monofilament Mesh |
| Mentor Worldwide LLC | $67.84 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| W. L. Gore & Associates, INC. | $58.88 | 2025 | Gore Bio-A Tissue Reinforcement |
| Ethicon US, LLC | $37.78 | 2020 | |
| Kerecis Limited | $36.95 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tei Biosciences INC | $21.11 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $7.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sisco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.